CARsgen Therapeutics (HKG:2171) released 2,667,000 options to 31 grantees under its post-initial public offering share option scheme, according to a Tuesday filing with the Hong Kong Exchange.
The options represent 2,667,000 shares with an exercise price of HK$7.26 per share, the filing said.
Director Hua Jiang will receive 200,000 options while the rest of the employees will get an aggregate of 2,467,000 options, the filing said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。